´ëÇѺÎÀÎÁ¾¾çÇÐȸ Chemo-TIP Review Course 2024 : 2024-01-13 |
|
´ëÇѺÎÀÎÁ¾¾çÇÐȸ Chemo-TIP Review Course 2024 : 2024-01-13 ±³À°ÁÖÁ¦ : Chemo-TIP Review Course 2024 ÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ À̸ÞÀÏ : office@sgo.or.kr ±³À°Á¾·ù : »êºÎÀΰú Âü¼®¿¹»óÀÎ : 150¸í Áö¿ª : ¼¿ïƯº°½Ã ¼¼ºÎ¼ö°·á : 80,000¿ø ºñ°í Àü¹®ÀÇ 80,000 ¿ø / Àü°øÀÇ 60,000 ¿ø / ¿¬±¸¿ø°£È£»ç 40,000 ¿ø / ¸¸ 65¼¼ÀÌ»ó, Ã⿬Áø ¹«·á
±³À°½Ã°£ 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 09:00~09:20 Conventional cytotoxics and targeted agents ±è¼¼ÀÍ(¼¿ïÀÇ´ë) ±³À°½Ã°£ 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 09:20~09:35 PARP inhibitors ¿À¿µÅÃ(°í·ÁÀÇ´ë) ±³À°½Ã°£ 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 09:35~09:50 Immuno-oncologics À¯Áö±Ù(°¡Å縯ÀÇ´ë) ±³À°½Ã°£ 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 09:50~10:05 Broadening the indications ¹ÚÁ¤¿(¿ï»êÀÇ´ë) Åä·Ð 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 10:05~10:20 Q&A ( ) ±³À°½Ã°£ 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 10:20~10:40 RECIST criteria version 1.1 ¹Ú¼ººó(Áß¾ÓÀÇ´ë) ±³À°½Ã°£ 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 10:40~11:00 Case review: tumor evaluation ÃÖ¹Îö(Â÷ÀÇ´ë) ±³À°½Ã°£ 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 11:00~11:15 Q&A ( ) ÈÞ½Ä 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 11:15~11:35 Coffee break ( ) ±³À°½Ã°£ 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 11:35~11:55 Ç×¾Ï °ø°í¾È (2022.8.1 °³Á¤) ÀÓÇöÁö(¼¿ïÀÇ´ë) ±³À°½Ã°£ 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 11:55~12:10 ½ÇÁ¦ º¸Çè½É»ç »ç·Ê ¹× ÁÖÀÇ»çÇ× ±è»óÈñ(¼º±Õ°üÀÇ´ë) Åä·Ð 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 12:10~12:20 Q&A ( ) ±³À°½Ã°£ 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 12:20~12:40 Prevention of herpes zoster in gynecologic cancer patients ±¸À¯Áø(¿µ³²ÀÇ´ë) ½Ä»ç 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 12:40~13:20 Lunch ( ) ±³À°½Ã°£ 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 13:20~13:35 Chemotherapy-induced nausea and vomiting Á¶¾ÈÁ©¶ó(Á¦ÁÖÀÇ´ë) ±³À°½Ã°£ 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 13:35~13:50 Cancer-related fatigue ¹Ú¼öÁø(¼¿ïÀÇ´ë) ±³À°½Ã°£ 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 13:50~14:05 Chemotherapy-induced peripheral neuropathy ÀÌ¿ëÀç(¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 14:05~14:20 Hematologic toxicity ±è½ÂÈ£(ÇѸ²ÀÇ´ë) ±³À°½Ã°£ 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 14:20~14:35 Non-hematologic toxicity & hypersensitivity ¼ÕÁÖÇõ(¾ÆÁÖÀÇ´ë) Åä·Ð 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 14:35~14:55 Q&A ( ) ±³À°½Ã°£ 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 14:55~15:15 Management of immunotherapy-related toxicities ÃÖöÈÆ(¼º±Õ°üÀÇ´ë) ±³À°½Ã°£ 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 15:15~15:40 Case review: adverse effect of I/O drug ÀÌÁ¤À±(¿¬¼¼ÀÇ´ë) Åä·Ð 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 15:40~16:00 Q&A ( ) ÈÞ½Ä 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 16:00~16:20 Coffee break ( ) ±³À°½Ã°£ 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 16:20~16:40 Epithelial ovarian cancer Á¶Çö¿õ(°í·ÁÀÇ´ë) ±³À°½Ã°£ 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 16:40~17:00 Uterine cancer ³ëÁØÈ£(¼º±Õ°üÀÇ´ë) ±³À°½Ã°£ 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 17:00~17:20 Cervical cancer °¿ÁÁÖ(¿ï»êÀÇ´ë) Åä·Ð 01¿ù 13ÀÏ ¸¶¸®¾ÆȦ 17:20~17:30 ¡Ú Prize Draw ¡Ú ³ëÁØÈ£(¼º±Õ°üÀÇ´ë)
|
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|